At concentrations below the MIC, paldimycin induced changes in Staphylococcus aureus 502A (UC 9116, ATCC28417) which increased its sensitivity to serum. The enhanced sensitivity to serum was concentration dependent with the maximal sensitivity found when bacteria were grown in approximately 1/10 MIC of paldimycin. Within an 1-hour incubation, S. aureus 502A typically grew 1.5~2-fold in serum. Following exposure to paldimycin, however, approximately 3O~5O%of the bacteria were killed in serum. The paldimycin treated bacteria were not more susceptible to phagocytosis and killing by polymorphonuclear leukocytes. At the concentrations utilized, the Staphylococci were enlarged and had thickened cell walls. The organisms were still viable and replicating, but irregularities in cell division were observed in transmission electron micrographs.
Sublethal concentrations of antibiotics can affect bacterial morphology and surface determinants, toxin production, adhesion, and their rate of growth. These antibiotic-induced changes in bacteria can enhance their susceptibility to various host defense mechanisms1"1^. Direct correlations between the ability of antibiotics to augment host defenses and clinical efficacy have not definitively been established. Nevertheless, a better understanding of an antibiotic effect in vivo might be obtained through the investigation of antibiotic/host defense interactions. In the present study, the effects of subinhibitory levels of paldimycin on the susceptibility of Staphylococcus aureus 502A (UC 9116, ATCC28417) to killing by serum lysis or polymorphonuclear leukocytes (PMLs) were studied. Numerousantibiotics have been shownto enhance either one or both of these host defense mechanisms, including the lincosaminides, the spectinomycmsn~14), certain /3-lactams15~20), chloramphenicol20>21), tetracycline20), and vancomycin17). Gentamicin was found to have no effect12»22»23). Paldimycin has a novel structure, however, and so its ability to enhance these mechanisms was of interest. Paldimycin is structurally related to the paulomycins which were originally isolated from fermentations of Streptomyces paulusM*25\ It has in vitro and in vivo activity against a variety of pathogenic organisms26 ' 270.
Materials and Methods

Chemicals
Paldimycin (U-70138F) and clindamycin (U-21251F) were obtained at The Upjohn Company. HBSS/HEPESbuffer was prepared by the addition of 10%Hanks balanced salt solution (10 x concentrated without calcium, magnesium, phenol red, and sodium bicarbonate) to 0.02 m HEPESbuffer (N-2-hydroxyethylpiperazine-A/r/-2-ethanesulfonic acid), pH 7.4.
Microorganism and Growth Conditions S. aureus 502A (UC 9116, ATCC28417) was used for all experiments. This organism exhibits high level resistance to serum lysis and PMLkilling in vitron>28K Stock cultures, frozen in 0.5 ml aliquots at -20°C, were used as inoculum for 100 ml nutrient broth, pH 7 
Assay Protocol
Phagocytic killing or serum lysis of S. aureus was determined as follows. Washed bacteria (0.5 ml), treated with antibiotic or untreated, were incubated with either 0.5 ml serum (10~100%) or 0.5 ml of the leukocytes in 10% serum (see above). The resulting suspension was mixed slowly by rocking for 45 minutes at 37°C in a sterile Nunc cryotube (90 x 125 mm). Duplicate tubes were prepared for each different mixture tested. The cfu present in the suspensions were determined before and after incubation. Before quantifying the surviving bacteria, the suspensions containing PMLswere subjected to mild sonic disruption for 5 seconds using a BronsonSonic Oscillator at a powersetting of 1. This exposure was sufficient to lyse intact PMLsand to disrupt clumps of S. aureus without killing the bacteria. This procedure was not necessary in assay mixtures containing only serum and bacteria.
MIC Determination The MICof paldimycin was determined using the growth conditions described, except the cultures were grown for 18 hours. The MICvalue obtained was 3.0^g/ml. As shown in Fig. 1 , the organism can grow in the presence of paldimycin at levels below the MIC, but at a slower rate than control cultures.
Transmission Electron Microscopy
For electron microscopic examination, samples were pelleted by centrifugation then fixed with 3 % glutaraldehyde in 0.1 m cacodylate (pH 7.2), and allowed to fix for 1 hour at room temperature. Following 3 rinses in buffer (0.1 m cacodylate, pH 7.2), cells were post-fixed in 1 % osmium tetroxide in buffer for 1 hour. Cells were then rinsed 3 times with distilled water, and stained for 30 minutes in 1 % aqueous uranyl acetate. Following 2 water rinses, cells were dehydrated with graded ethanols through 100%, cleared in propylene oxide, and embedded in Polybed 812 (Polysciences, Inc.). Thin sections were cut with diamond knives on an MT-5000ultramicrotome (Dupont-Sorvall), stained with Reynolds lead citrate29), viewed and photographed on a Jeol 1200EXscanning-transmission electron microscope.
Results
Effect of Paldimycin on the Susceptibility of £. aureus to Serum S. aureus 502A is resistant to the bactericidal action of serum. Whenwashed, untreated Staphy- lococci were incubated with serum, an increase in cfu of approximately 2-fold occurred within 1 hour. Bacteria grown in subinhibitory levels of paldimycin, however, became susceptible to serum lysis as shown in Table 1 . The bactericidal activity of the serum varied in each experiment, but killing was consistently found with S. aureus exposed to 1/10 MIC (0.3^g/ml) of antibiotic. When lower concentrations of paldimycin were utilized, growth in serum was always inhibited, but killing was not observed in every experiment.
Effects of Paldimycin on the Killing of S. aureus by PMLs S. aureus 502A is phagocytosed by PMLs, but a small percentage do survive within the phagolysosome and multiply27). The in vitro susceptibility of the organism to PMLkilling is dependent upon the growth phasen). Table 2 shows that 5-hour cultures are resistant to PMLkilling, whereas an average of 53 % of the bacteria in 4-hour cultures are killed within a 45-minute incubation with PMLs. Pretreatment with paldimycin did not alter the susceptibility of either a 4-or 5-hour culture. No enhancement of killing was detectable.
Comparison of Clindamycin and Paldimycin in Enhancing
Host Defense Mechanisms Clindamycin has been widely tested for its ability to augment host defense mechanisms8'n~14). a Bacteria (5~8 x 107/ml) were incubated with either 50%serum or PMLs (107/ml) in 10% serum for 45 minutes. b Results are expressed as percentages of the viable number of bacteria at 0 time surviving after 45 minutes incubation and are the mean of 5 or more experiments. Bar represents 0.5 /im. MAY 1988 Enhanced phagocytic killing of bacteria following growth in subinhibitory levels of clindamycin has been repeatedly shown. However,clindamycin has been reported to have no effect on the serum sensitivity of S. aureusn\ Therefore, as a control experiment, clindamycin and paldimycin were tested simultaneously in our assay ( Table 3) . As expected, enhanced PMLkilling of S. aureus grown with 1/3 MICof clindamycin was found. No enhancement was observed when S. aureus was grown in 1/10 MICof paldimycin. However, the susceptibility of the Staphylococci to serum increased following exposure to paldimycin, but not to clindamycin. Clindamycin-treated bacteria remained resistant to serum.
Electron Micrographs of S. aureus Morphological alterations in S. aureus following exposure to varying concentrations of paldimycin were observed by transmission electron microscopy (Fig. 2) . Following exposure to paldimycin in nutrient broth, bacteria were found to increase in diameter in a dose-dependent manner when compared to untreated control cultures. Additionally, considerable thickening of the cell wall was observed. At the highest concentration tested (Fig. 2d ), cells were approximately 2-fold larger than controls (0.54 jum in controls to 0.96^m in treated), and cell wall-thickness was approximately 4-fold greater (1.5 nm in controls to 6.2 nm in treated). Few indications of cell division were observed in the highest level of paldimycin. At lower concentrations, abnormalities in cell division were apparent (Figs. 2b and 2c) . Peripheral mesosomes were frequently observed also.
Discussion
Although the main therapeutic effect of an antibiotic is to kill bacteria or inhibit their growth, the results of this study and those of other investigations8"2^suggest that even at subinhibitory levels, certain antibiotics can alter bacteria making them more susceptible to host defenses. Such low levels of antibiotic maybe found in serum after peak titers have fallen or at tissue sites of infection. Paldimycin at sub-MIC levels augmented serum killing of S. aureus 502A. An average of 41 % of the bacteria were killed following exposure to only 1/10 MICof the antibiotic. At lower levels, their growth in serum was inhibited or greatly reduced compared to untreated bacteria. This rate of serum killing is similar to that found when 8. aureus (ATCC25923) was exposed to subinhibitory levels of cefamandole1 6).
Paldimycin has been demonstrated to inhibit protein synthesis30). The cell wall thickening and the irregularities in cell division observed in the Staphylococci exposed to paldimycin have been observed using other antibiotics with this mode of action, such as the lincosaminides and certain macrolides, and is also characteristic of starvation for a non-peptidoglycan essential aminoacid16»31'32).
Antibiotic induced morphological changes in bacteria, such as these, which alter surface characteristics have been associated with increased susceptibility to various host defense factors, including serum13'16'33). Although Gram-positive bacteria are not generally sensitive to the bactericidal activity of serum, the ultrastructural changes induced by treatment with paldimycin could alter the antigenicity of the S. aureus 502Athus making them susceptible to serum. Augmentation of host defense mechanisms by antibiotics, such as observed with paldimycin, could explain whycertain antibiotics exhibit greater efficacy in vivo than predicted from in vitro bioactivities.
Although the clinical significance of these observations remains to be established, investigation of synergistic effects between antibiotics and host defense mechanisms should provide a better understanding of the antimicrobial activity of an antibiotic in vivo.
